REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 63 filers reported holding REPARE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,124,477 | -99.9% | 144,424 | +18.0% | 0.00% | 0.0% |
| Q3 2022 | $1,484,032,000 | -24.6% | 122,344 | -13.1% | 0.00% | 0.0% |
| Q2 2022 | $1,969,415,000 | -5.3% | 140,773 | -3.6% | 0.00% | 0.0% |
| Q1 2022 | $2,078,897,000 | -37.5% | 145,990 | -7.4% | 0.00% | 0.0% |
| Q4 2021 | $3,323,869,000 | -21.1% | 157,604 | -1.8% | 0.00% | -50.0% |
| Q3 2021 | $4,211,494,000 | -18.6% | 160,499 | -3.3% | 0.00% | 0.0% |
| Q2 2021 | $5,176,473,000 | -7.2% | 166,019 | -8.6% | 0.00% | 0.0% |
| Q1 2021 | $5,576,096,000 | -8.0% | 181,691 | +2.8% | 0.00% | -33.3% |
| Q4 2020 | $6,062,285,000 | +5.2% | 176,743 | -5.6% | 0.00% | 0.0% |
| Q3 2020 | $5,762,267,000 | +0.6% | 187,269 | +1.4% | 0.00% | -25.0% |
| Q2 2020 | $5,730,449,000 | – | 184,734 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,646,657 | $31,971,617 | 17.00% |
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $27,091,043 | 14.51% |
| CHI Advisors LLC | 2,966,674 | $35,837,422 | 14.20% |
| MPM BioImpact LLC | 1,639,849 | $19,809,376 | 5.29% |
| BVF INC/IL | 8,291,988 | $100,167,215 | 2.70% |
| Deep Track Capital, LP | 3,067,731 | $37,058,190 | 1.43% |
| Redmile Group, LLC | 2,404,695 | $29,048,716 | 1.38% |
| HighVista Strategies LLC | 165,173 | $1,995,290 | 0.92% |
| Orbimed Advisors | 3,322,488 | $40,135,655 | 0.85% |
| Logos Global Management LP | 500,000 | $6,040,000 | 0.81% |